Navigation Links
Franck's Compounding Lab Purchases Wisconsin Pharmacy
Date:12/12/2007

OCALA, Fla., Dec. 12 /PRNewswire/ -- Franck's Compounding Lab of Ocala, Florida announced today the acquisition of Island Pharmacy Services in Woodruff, Wisconsin. Island Pharmacy owners, Randy Reek and Dave Rice, R.Ph., have decided to pursue other personal interests. Selling their pharmacy to Franck's Compounding Lab was based on a business decision made to ensure the continuance of high quality prescriptions and customer service. "The purchase of Island Pharmacy adds a tremendous opportunity for us to expand our full service veterinary compounding business," said Paul Franck, R.Ph., Owner and CEO of Franck's Pharmacy.

This buyout will add about 8,000 patients and 4,000 prescribing veterinarians to the Florida based compounding lab. Franck's Compounding Lab currently employs over 75 people and has pharmacists licensed to compound prescriptions nationwide in all states requiring licensure.

About Franck's Compounding Lab

One of the nation's largest compounding pharmacies, the Florida based Franck's Compounding Lab has been recognized nationwide for exceptional standards in the art of custom compounds for people and companion animals. As a leader in the field of compounding, Franck's Compounding Lab exceeds USP Chapter 797 guidelines for sterile compounding and maintains a valid DEA license to allow the compounding of controlled substances. In 2008 Franck's Pharmacy will celebrate 25 years of nationwide service.

Please visit the Franck's Pharmacy website at http://www.francks.com. For more information please call Jennifer Beckett 352-622-2913 extension 268 or email jbeckett@francks.com


'/>"/>
SOURCE Franck's Compounding Lab
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
2. Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding
3. Dixtal Medical Purchases Novametrix Pulse Oximetry Business from Respironics
4. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
5. Hospital Corporation of America Purchases Seventh CyberKnife(R) System
6. CorVel Corporation Announces Resumption of Stock Repurchases
7. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
8. March of Dimes NICU Family Support(R) Programs Give Wisconsin Families Comfort and Information during a Crisis
9. Sonic Foundry to Host Wisconsin Lt. Governor Lawton in Raising Awareness for National Depression Screening Day
10. Medical College of Wisconsin receives FDA grant
11. Medical College of Wisconsin study finds drug may limit radiation kidney damage in BMT patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 As obesity rates sky ... need for surgical equipment during childbirth comes as no shock. ... within the mother when she is unable to do so ... are associated with higher rates of complication for both the ... harmful to the mother and child, forceps births add to ...
(Date:6/18/2013)... WA (PRWEB) June 18, 2013 SEATTLE, ... Townsend Farms of Fairview, Oregon, claiming he fell ill ... frozen berry and pomegranate seed blend. The complaint ... 13-2-05597-8) by Marler Clark, the Seattle-based law firm that ... .[1] , According to the complaint, Brian Brothers consumed ...
(Date:6/18/2013)... The Drug Delivery Partnering Terms and Agreements ... drug delivery partnering deals and agreements entered into by ... provides a detailed understanding and analysis of how and ... of deals are discovery or development stage whereby the ... license the license drug delivery technology. These deals tend ...
(Date:6/18/2013)... The Temp1000IS temperature data logger ... can be used to automatically record temperatures between -20 ... Temp1000IS comes with the serial number and device name ... (sold separately) docking station and can be placed directly ... removal of end-caps to download data. The small size ...
(Date:6/18/2013)... Parker Waichman LLP , a ... victims injured by defective medical devices, reports that the ... bone graft products are now available. Published this week ... two studies serve up two key findings: There is ... and the traditional bone graft; and there is “substantial ...
Breaking Medicine News(10 mins):Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:MadgeTech, Inc. Introduces the New Temp1000IS Intrinsically Safe High Temperature Data Logger 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3
... Reinberg HealthDay Reporter , WEDNESDAY, May 25 ... a "polypill," appears to cut users, odds for heart ... study finds. The pill combines two blood pressure-lowering ... designed to make all these heart-protecting drugs easy to ...
... 25, 2011) The cost of cancer care is threatening ... but at staggering costs. This coupled with aging baby boomers ... billion annually on cancer care by the year 2020. This ... maintain or improve the quality of care while saving money ...
... CA (May 26, 2011) Precision tinted lenses have ... poor readers, and are increasingly used for migraine sufferers, ... been unclear. Now research published in the journal ... imaging (fMRI) for the first time to suggest a ...
... NY, May 26, 2011Young adults ages 19-29 are struggling to ... other age group, demonstrating the need for Affordable Care Act ... and make it more affordable, according to a new Commonwealth ... of young adults couldn,t afford the care they needed, meaning ...
... 2011 UT Southwestern Medical Center researchers are engaging the ... component in red wine and grapes could help reduce the ... recruit about two dozen professional boxers to take the neuroprotective ... damage to the brain after impact and helps restore subtle ...
... bats and dolphins echolocate, emitting bursts of sounds and then ... What is less well-known is that people can echolocate too. ... make clicks with their mouths and to use the returning ... these individuals are so adept at echolocation that they can ...
Cached Medicine News:Health News:Daily Four-Drug Combo Pill Halves Heart Disease Risk: Study 2Health News:Daily Four-Drug Combo Pill Halves Heart Disease Risk: Study 3Health News:Oncologists hold key to curbing cancer costs 2Health News:Oncologists hold key to curbing cancer costs 3Health News:Tinted specs offer real migraine relief, says fMRI study 2Health News:Tinted specs offer real migraine relief, says fMRI study 3Health News:Health reform essential to young adults: Nearly half can't afford needed health care 2Health News:Health reform essential to young adults: Nearly half can't afford needed health care 3Health News:Health reform essential to young adults: Nearly half can't afford needed health care 4Health News:Researchers evaluate red wine compound for treating concussions in pro boxers 2Health News:'I can hear a building over there' 2
(Date:6/18/2013)... June 18, 2013 Valeant Pharmaceuticals International, Inc. ... "Company") announced today that VPII Escrow Corp., a newly ... launched its offer of approximately $3.2 billion aggregate principal ... will be due in 2021 and in 2023, with ... intends to use the net proceeds from the offering, ...
(Date:6/18/2013)... YORK , June 18, 2013  Intercept Pharmaceuticals, ... biopharmaceutical company focused on the development and commercialization of ... today announced the pricing of an underwritten public offering ... public offering price of $33.01 per share.  In addition, ... purchase up to an additional 259,500 shares of common ...
(Date:6/18/2013)... , June 18, 2013 Valeant Pharmaceuticals ... VRX) has priced its previously announced public offering of ... Company will issue 23,529,412 common shares at a price ... approximately $2.0 billion. The Company will file a final ... Form S-3 and will make a similar filing with ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4
... announced that data,presented recently at the 17th Annual ... that the Genous Bio-engineered R,stent has better outcomes ... Federico Piscione, M.D., the study,s principal,investigator and a ... of Cardiology, Department of Clinical Medicine and Cardiovascular,Sciences, ...
... Results are basis for CTI,s Marketing Authorization Application currently ... under ... Inc. (CTI),(Nasdaq: CTIC ; MTA) today announced the publication of ... gemcitabine or vinorelbine for the treatment of PS 2,(performance status 2) ...
Cached Medicine Technology:Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The BD Vacutainer® One Use Holder is a quality, low-cost single use holder that can help customers comply with OSHA regulations (Safety and Health Information Bulletin 10-15-03)...
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Inquire...
Medicine Products: